The Power of Synthetic Biology: Innovations and Implications

Synthetic biology can contribute to drug and vaccine development advances in pest control of invasive species. In response to the COVID-19 pandemic, synthetic biologists are applying cutting-edge tools to speed up the development of a successful vaccine. Their efforts illustrate synthetic biology's potential to design, build, and test solutions for an unanticipated challenge such as COVID-19. Additionally, in the COVID-19 pandemic, synthetic biology was viewed as the next step in the advancement of vaccination development. It was being used as a design tool to make vaccines more effective than ever.

Also, the Cambridge laboratory used synthetic biology to locate a critical area of the virus's genetic code that helped to develop a vaccine ready for testing within a very short time frame. At the same time, Twist Bioscience also announced the availability of synthetic SARS-CoV-2 RNA controls to provide quality control for the development, verification, and ongoing validation of diagnostic tests. Therefore, the demand for synthetic biology services continued to grow through the COVID-19 pandemic, thereby ensuring continued growth.

Download Sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPHE100000960/?utm_source=OpenPR&utm_medium=10776

The global healthcare system was severely challenged by an explosive surge of COVID-19 positive cases, which resulted in a significant increase in the demand for medical care. The government released interim and updated guidelines for clinical management of patients with confirmed COVID-19, which included its clinical presentation, transmissions, and the clinical course of action against the disease. According to MolecularCloud, a platform sponsored by GenScript, In the fight against the current pandemic, scientists are turning to synthetic biology to hurry up the development of a vaccine. In the drug discovery pipeline, in many areas, the speed and accuracy of the latest synthetic biology tools are creating a measurable distinction within the ability to accelerate drug development while at the same time reducing expenses.

According to our new research study on "Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Products (Enzymes, Chassis Organisms, Oligonucleotides, and Xeno-Nucleic Acids), Technology (Measurement & Modeling, Cloning & Sequencing, Genome Engineering, Gene Synthesis, Nanotechnology, and Others), and Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications, and Others), the market is expected to reach US$ 37,850.85 million by 2028 from US$ 10,544.16 million in 2021; it is estimated to grow at a CAGR of 20.0% during 2021-2028.

By geography, the global synthetic biology market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of the MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America)

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.